Invention Grant
US07645760B2 1-(4-Benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
失效
1-（4-苄基 - 哌嗪-1-基）-3-苯基 - 丙烯酮衍生物
- Patent Title: 1-(4-Benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
- Patent Title (中): 1-（4-苄基 - 哌嗪-1-基）-3-苯基 - 丙烯酮衍生物
-
Application No.: US10532331Application Date: 2003-10-24
-
Publication No.: US07645760B2Publication Date: 2010-01-12
- Inventor: Birgit Bollbuck , Jorg Eder , Richard Heng , Laszio Revesz , Achim Schlapbach , Rudolf Walchli
- Applicant: Birgit Bollbuck , Jorg Eder , Richard Heng , Laszio Revesz , Achim Schlapbach , Rudolf Walchli
- Applicant Address: CH Based
- Assignee: Novartis AG.
- Current Assignee: Novartis AG.
- Current Assignee Address: CH Based
- Agent Sophie Binet Cross
- Priority: GB0224917.5 20021025
- International Application: PCT/EP03/11848 WO 20031024
- International Announcement: WO2004/037796 WO 20040506
- Main IPC: C07D241/10
- IPC: C07D241/10 ; C07D295/027 ; A61K31/4965
Abstract:
A compound of formula (I), or a pharmaceutically acceptable salt or ester thereof, wherein the symbols have meaning as defined, which are antagonists of CCR-1 and which find use pharmaceutically for treatment of diseases and conditions in which CCR-1 is implicated, e.g. inflammatory diseases.
Public/Granted literature
- US20060173004A1 1-(4-Benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives Public/Granted day:2006-08-03
Information query
